Research dossier

GHRP-2 (pralmorelin) — dossier on the second-generation GHRP secretagogue

The only GHRP to have obtained a marketing authorisation — in Japan, as a diagnostic agent.

7 min read · Purpeptide Research Desk ·

Translated from the French original, which remains the reference version: lire en français →

The GHRP-2 hexapeptide, with its D-alanine and D-2-naphthylalanine at the head of the chain, binding to the GHS-R1a ghrelin receptor

GHRP-2 — international nonproprietary name pralmorelin — is a synthetic hexapeptide of the GHRP (growth hormone-releasing peptides) family. It was developed in the early 1990s in the line of GHRP-6, with a modified sequence at the head of the chain.

This dossier describes its identity, its studied mechanism, its particular regulatory status and its analytical parameters. It contains no information on use.

Molecular identity

ParameterValue
CAS number158861-67-7
Molar mass817.98 g/mol
Molecular formulaC₄₅H₅₅N₉O₆
Sequence / natureD-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂
Purity≥99%
AppearanceWhite lyophilised powder

The values above are those of the product page. “D-2-Nal” designates D-2-naphthylalanine, a non-natural amino acid.

Lineage from GHRP-6

GHRP-2 retains the last four amino acids of GHRP-6 (Ala-Trp-D-Phe-Lys-NH₂). It replaces the first two: the histidine becomes a D-alanine, and the D-tryptophan becomes a D-2-naphthylalanine. These two changes give it a distinct profile, with a GH-releasing potency described as greater than that of GHRP-6.

Mechanism studied: the GHS-R1a receptor

Like the other GHRPs, GHRP-2 activates the GHS-R1a receptor, the ghrelin receptor, in the pituitary and hypothalamus. This pathway is distinct from that of GHRH and its analogues such as sermorelin or CJC-1295.

GHRP-2 is not selective for GH. The published studies also describe an elevation of ACTH, cortisol and prolactin. Like GHRP-6, it has been associated with an increase in food intake in some work, consistent with its action at the ghrelin receptor.

An authorisation in Japan, as a diagnostic agent

Pralmorelin has been marketed in Japan since 2004 by Kaken Pharmaceutical under the name GHRP Kaken 100. It is used there as a single dose for the diagnosis of growth hormone deficiency: the GH response is strong in healthy subjects and distinctly weaker where there is a deficiency.

This is to date the only marketing authorisation obtained by a peptide of the GHRP family. It does not extend to the European Union. GHRP-2 is not authorised as a medicine in France and appears in section S2 of the World Anti-Doping Agency prohibited list. See our article on the legal framework for peptides in France.

Telling GHRP-2 apart from its analogues

CritèreGHRP-2GHRP-6HexarelinIpamorelin
Length6 amino acids6 amino acids6 amino acids5 amino acids
Molecular mass817.98 g/mol873.01 g/mol887.04 g/mol711.86 g/mol
Selectivity for GHLowLowLowHigh
AuthorisationDiagnostic, JapanNoneNoneNone

Methodological limits

The literature on GHRP-2 is rich in short pharmacological studies, often in small numbers of participants. Long-term data are scarce. As with the other GHRPs, an attenuation of the response during prolonged exposure has been described.

Analytical parameters

At 817.98 g/mol, GHRP-2 is distinctly lighter than GHRP-6 (873.01 g/mol) and hexarelin (887.04 g/mol). The gap of about 55 daltons from GHRP-6 is easily resolved by mass spectrometry.

D-2-naphthylalanine, being highly hydrophobic, lengthens the retention time in reverse-phase HPLC compared with GHRP-6. Identity confirmation by mass remains indispensable: chromatographic purity alone does not say which GHRP is in the vial. See our guide to reading an analysis report.

Lot verification

The Janoshik certificates of analysis for the catalogue are collected in the lot report register, where each report is tied to the strength and the lot it analyses.

Frequently asked questions

Do GHRP-2 and pralmorelin designate the same compound?

Yes. Pralmorelin is the international nonproprietary name of GHRP-2.

What is the difference between GHRP-2 and GHRP-6?

The first two amino acids: D-alanine and D-2-naphthylalanine for GHRP-2, histidine and D-tryptophan for GHRP-6. GHRP-2 is described as more potent on GH release.

Is GHRP-2 a medicine?

In Japan only, as a single-dose diagnostic agent (GHRP Kaken 100). It is not authorised in France.

Is GHRP-2 selective for growth hormone?

No. It also raises ACTH, cortisol and prolactin. Ipamorelin is the GHRP characterised for its selectivity.

See also: CJC-1295, Ipamorelin, GHRP-6: GHRH and GHRP compared · Hexarelin: the dossier

Dossiers in the same category

References

  • Chihara K, et al. A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency. Eur J Endocrinol. 2007. PubMed
  • NCATS Inxight Drugs. Pralmorelin. drugs.ncats.io

Related dossiers

All research dossiers → · Catalogue → · Glossary →